- Home
- IPDN vs LGVN Comparison
IPDN vs LGVN Comparison
Compare IPDN & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- LGVN
- Stock Information
- Founded
- IPDN 2003
- LGVN 2014
- Country
- IPDN United States
- LGVN United States
- Employees
- IPDN N/A
- LGVN N/A
- Industry
- IPDN EDP Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- IPDN Technology
- LGVN Health Care
- Exchange
- IPDN Nasdaq
- LGVN Nasdaq
- Market Cap
- IPDN 4.4M
- LGVN 23.4M
- IPO Year
- IPDN 2013
- LGVN 2021
- Fundamental
- Price
- IPDN $2.27
- LGVN $1.47
- Analyst Decision
- IPDN
- LGVN Strong Buy
- Analyst Count
- IPDN 0
- LGVN 3
- Target Price
- IPDN N/A
- LGVN $8.67
- AVG Volume (30 Days)
- IPDN 2.9M
- LGVN 715.2K
- Earning Date
- IPDN 08-12-2025
- LGVN 08-13-2025
- Dividend Yield
- IPDN N/A
- LGVN N/A
- EPS Growth
- IPDN N/A
- LGVN N/A
- EPS
- IPDN N/A
- LGVN N/A
- Revenue
- IPDN $6,508,349.00
- LGVN $2,225,000.00
- Revenue This Year
- IPDN N/A
- LGVN N/A
- Revenue Next Year
- IPDN N/A
- LGVN $51.48
- P/E Ratio
- IPDN N/A
- LGVN N/A
- Revenue Growth
- IPDN N/A
- LGVN 127.50
- 52 Week Low
- IPDN $0.97
- LGVN $1.14
- 52 Week High
- IPDN $11.20
- LGVN $4.88
- Technical
- Relative Strength Index (RSI)
- IPDN 54.52
- LGVN 57.16
- Support Level
- IPDN $2.10
- LGVN $1.37
- Resistance Level
- IPDN $2.64
- LGVN $1.40
- Average True Range (ATR)
- IPDN 0.45
- LGVN 0.12
- MACD
- IPDN -0.00
- LGVN 0.02
- Stochastic Oscillator
- IPDN 25.42
- LGVN 47.70
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.